Clinically T1N0 gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Clinically diagnosed T1N0 early gastric cancer 2) Single lesion 3) Less than 40mm in size 4) Provided written informed concent 5) Histopathological type does not matter
Exclusion criteria
Exclusion criteria: 1) Pregnancy, severe drug allergy, asthoma. 2) Multiple lesion 3) With prior treatment to same lesion 4) Synchronous or metachronous (within 5 years) malignancies. 5) Judged as irrelevant object for this study 6) Refusal of the trial entry 7) Remnant gastric cancer 8) Absolute indication for endoscopic treatments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative 5-year recurrence free survival(RFS) ratio | — |
Secondary
| Measure | Time frame |
|---|---|
| postoperative 3-year RFS rate, postoperative 3/5-year overall survival, sentinel node detection rate, distribution, sensitivity, accuracy for lymph node metastases, quality of life after surgery | — |
Countries
Japan
Contacts
School of Medicine, Keio University Department of Surgery